Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1297 Articles

Drew Wood | Jul 12, 2026 at 11:24 AM EDT

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

Two retirees can both pull $100,000 from $2 million income portfolios and still land in very different places after tax.…

Drew Wood | Jul 11, 2026 at 12:42 PM EDT

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

A 10% dividend feels like a win because it solves the income problem with less capital. The arithmetic is seductive:…

Drew Wood | Jul 11, 2026 at 11:30 AM EDT

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

A stock screener sorted by current yield misses one of the most powerful income stories in the market. Microsoft (NASDAQ:…

Drew Wood | Jul 11, 2026 at 10:15 AM EDT

The Retirement Budget Most People Build Is Backward

Most retirement budgets start with the wrong question. The instinct is to ask, “What yield do I need so the…

Ian Cooper | Jul 11, 2026 at 8:19 AM EDT

Volatility Isn’t the Risk You Should Fear — These Are

Most investors panic when stocks turn red, but the losses that actually destroy wealth rarely show up on a bad…

Drew Wood | Jul 10, 2026 at 3:00 PM EDT

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

Replacing $7,500 a month with dividends is a math problem before it is anything else. The number you need to…

Drew Wood | Jul 10, 2026 at 12:30 PM EDT

A Dividend Portfolio That Pays For Your Pets

Rescuing a dog or cat can easily turn into a 10- to 20-year financial commitment. Medium-sized dogs often live around…

David Moadel | Jul 10, 2026 at 12:04 PM EDT

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Moderna, ImmunityBio, and Sarepta are all cratering today despite bullish recent news and no negative catalysts in sight, leaving investors…

Vandita Jadeja | Jul 10, 2026 at 11:30 AM EDT

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

JNJ and AbbVie both beat revenue expectations in Q1 2026, yet their strategies could not look more different, and which…

Danielle Liverance | Jul 10, 2026 at 10:08 AM EDT

5 Words A Dividend Investor Never Wants To Hear, And Three Signs You Are About To Hear Them.

A dividend cut does not announce itself in advance, but the warning signs appear in the financials long before management…

Drew Wood | Jul 10, 2026 at 9:12 AM EDT

What Would It Take to Permanently Cover Long-Term Care Insurance Premiums?

A long-term care policy does not just protect against a future care bill. It also creates a premium bill that…

Drew Wood | Jul 10, 2026 at 6:20 AM EDT

The 20-Year Dividend Strategy Built For Investors Who Don’t Need Income Yet

An investor who bought Microsoft (NASDAQ:MSFT | MSFT Price Prediction) ten years ago paid closer to $50 per share than…

Drew Wood | Jul 9, 2026 at 3:01 PM EDT

How Large Does Your Portfolio Need to Be to Generate $12,000 a Month?

Twelve thousand dollars a month sounds like a round number, but it carries weight. It works out to $144,000 a…

Danielle Liverance | Jul 9, 2026 at 2:45 PM EDT

Jim Cramer: Buy the Dip on These 3 Stocks Now

A sharp sector rotation has knocked down some of the market’s steadiest names, and Jim Cramer told CNBC viewers this…

Thomas Richmond | Jul 9, 2026 at 11:57 AM EDT

Fundstrat’s Tom Lee: AI Is a Once in a Lifetime Story – Why Easing Inflation in H2 2026 Could Fuel the Next Rally

Fundstrat’s Tom Lee returned to CNBC’s Morning Call Sheet on Thursday, July 9, alongside JonesTrading’s Mike O’Rourke and Vital Knowledge’s…

1 2 3 4 … 87

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

The Retirement Budget Most People Build Is Backward

Volatility Isn’t the Risk You Should Fear — These Are

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

A Dividend Portfolio That Pays For Your Pets

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

5 Words A Dividend Investor Never Wants To Hear, And Three Signs You Are About To Hear Them.

What Would It Take to Permanently Cover Long-Term Care Insurance Premiums?

The 20-Year Dividend Strategy Built For Investors Who Don’t Need Income Yet

How Large Does Your Portfolio Need to Be to Generate $12,000 a Month?

Jim Cramer: Buy the Dip on These 3 Stocks Now

Fundstrat’s Tom Lee: AI Is a Once in a Lifetime Story – Why Easing Inflation in H2 2026 Could Fuel the Next Rally

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

The Retirement Budget Most People Build Is Backward

Volatility Isn’t the Risk You Should Fear — These Are

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

A Dividend Portfolio That Pays For Your Pets

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

5 Words A Dividend Investor Never Wants To Hear, And Three Signs You Are About To Hear Them.

What Would It Take to Permanently Cover Long-Term Care Insurance Premiums?

The 20-Year Dividend Strategy Built For Investors Who Don’t Need Income Yet

How Large Does Your Portfolio Need to Be to Generate $12,000 a Month?

Jim Cramer: Buy the Dip on These 3 Stocks Now

Fundstrat’s Tom Lee: AI Is a Once in a Lifetime Story – Why Easing Inflation in H2 2026 Could Fuel the Next Rally

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line